MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$3,027,002
EPS
-$0.68
Unit: Dollar
Income Statement
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Research and development
1,085,998
434,006
1,278,629
176,283
General and administrative
1,939,398
2,436,871
919,025
821,826
Total operating expenses
3,025,396
2,870,877
2,197,654
998,109
Loss from operations
-3,025,396
-2,870,877
-2,197,654
-998,109
Interest income
399
1,078
-
-
Interest expense
2,005
150
1,337
2,649
Total other expense, net
-1,606
928
-1,337
-2,649
Net loss
-3,027,002
-2,869,949
-2,198,991
-1,000,758
Net loss available to common shares
-
-2,869,949
-2,198,991
-1,000,758
Basic EPS
-0.68
-0.86
-0.58
-0.3
Diluted EPS
-0.68
-0.86
-0.58
-0.3
Basic Average Shares
4,478,709
3,337,143*
3,804,741
3,380,968
Diluted Average Shares
4,478,709
3,337,143*
3,804,741
3,380,968
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

ALZN Income Statement Sankey DiagramSankey diagram visualizing ALZN income statement for the periodNet loss-$3,027,002 (-12.00%↓ Y/Y)Loss from operations-$3,025,396 (-12.04%↓ Y/Y)Total other expense,net-$1,606 (35.32%↑ Y/Y)Interest income$399 Total operatingexpenses$3,025,396 (12.04%↑ Y/Y)Interest expense$2,005 (-19.25%↓ Y/Y)General andadministrative$1,939,398 (102.16%↑ Y/Y)Research and development$1,085,998 (-37.62%↓ Y/Y)

Alzamend Neuro, Inc. (ALZN)

Alzamend Neuro, Inc. (ALZN)